Dosing dilemma: Can reduced botulinum neurotoxin type-A doses offer longer-lasting effects in cervical dystonia?

IF 3.1 3区医学 Q2 CLINICAL NEUROLOGY Parkinsonism & related disorders Pub Date : 2024-11-14 DOI:10.1016/j.parkreldis.2024.107209

Avery Kundrick, Claire Sonneborn, Hubert H Fernandez

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

剂量难题：减少 A 型肉毒杆菌神经毒素的剂量能否为颈肌张力障碍患者带来更持久的疗效？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Parkinsonism & related disorders 医学-临床神经学

CiteScore

6.20

自引率

4.90%

发文量

292

审稿时长

39 days

期刊介绍： Parkinsonism & Related Disorders publishes the results of basic and clinical research contributing to the understanding, diagnosis and treatment of all neurodegenerative syndromes in which Parkinsonism, Essential Tremor or related movement disorders may be a feature. Regular features will include: Review Articles, Point of View articles, Full-length Articles, Short Communications, Case Reports and Letter to the Editor.

期刊最新文献

Unsupervised definition of two clinical subtypes of Essential tremor and the underlying brain topology. A challenging case of cerebellar ataxia associated with oro facial dominant chorea. The use of hypoglycemic drugs in Parkinson's disease: An updated meta-analysis of randomized controlled trials. Dosing dilemma: Can reduced botulinum neurotoxin type-A doses offer longer-lasting effects in cervical dystonia? Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic review.